Logo image of GXAI

GAXOS.AI INC (GXAI) Stock Fundamental Analysis

USA - NASDAQ:GXAI - US62911P3001 - Common Stock

1.72 USD
-0.01 (-0.58%)
Last: 9/12/2025, 8:00:01 PM
1.7106 USD
-0.01 (-0.55%)
After Hours: 9/12/2025, 8:00:01 PM
Fundamental Rating

3

GXAI gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 80 industry peers in the Entertainment industry. No worries on liquidiy or solvency for GXAI as it has an excellent financial health rating, but there are worries on the profitability. GXAI has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

In the past year GXAI has reported negative net income.
GXAI had a negative operating cash flow in the past year.
GXAI Yearly Net Income VS EBIT VS OCF VS FCFGXAI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2021 2022 2023 2024 -1M -2M -3M

1.2 Ratios

With a Return On Assets value of -23.62%, GXAI is not doing good in the industry: 77.50% of the companies in the same industry are doing better.
Looking at the Return On Equity, with a value of -24.23%, GXAI is in line with its industry, outperforming 42.50% of the companies in the same industry.
Industry RankSector Rank
ROA -23.62%
ROE -24.23%
ROIC N/A
ROA(3y)-92.62%
ROA(5y)N/A
ROE(3y)-114.35%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
GXAI Yearly ROA, ROE, ROICGXAI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2021 2022 2023 2024 -50 -100 -150 -200

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for GXAI so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
GXAI Yearly Profit, Operating, Gross MarginsGXAI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2021 2022 2023 2024 -200K -400K -600K -800K -1M

More info and screens

8

2. Health

2.1 Basic Checks

GXAI does not have a ROIC to compare to the WACC, probably because it is not profitable.
GXAI has more shares outstanding than it did 1 year ago.
There is no outstanding debt for GXAI. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
GXAI Yearly Shares OutstandingGXAI Yearly Shares OutstandingYearly Shares Outstanding 2021 2022 2023 2024 2M 4M 6M
GXAI Yearly Total Debt VS Total AssetsGXAI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2021 2022 2023 2024 5M 10M 15M

2.2 Solvency

An Altman-Z score of 18.37 indicates that GXAI is not in any danger for bankruptcy at the moment.
GXAI has a better Altman-Z score (18.37) than 97.50% of its industry peers.
GXAI has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 18.37
ROIC/WACCN/A
WACC8.7%
GXAI Yearly LT Debt VS Equity VS FCFGXAI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2021 2022 2023 2024 0 5M 10M 15M

2.3 Liquidity

GXAI has a Current Ratio of 28.68. This indicates that GXAI is financially healthy and has no problem in meeting its short term obligations.
GXAI has a better Current ratio (28.68) than 98.75% of its industry peers.
GXAI has a Quick Ratio of 28.68. This indicates that GXAI is financially healthy and has no problem in meeting its short term obligations.
GXAI has a Quick ratio of 28.68. This is amongst the best in the industry. GXAI outperforms 98.75% of its industry peers.
Industry RankSector Rank
Current Ratio 28.68
Quick Ratio 28.68
GXAI Yearly Current Assets VS Current LiabilitesGXAI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2021 2022 2023 2024 5M 10M 15M

More info and screens

1

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 51.92% over the past year.
The Revenue has grown by 1233.33% in the past year. This is a very strong growth!
EPS 1Y (TTM)51.92%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
Revenue 1Y (TTM)1233.33%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
GXAI Yearly Revenue VS EstimatesGXAI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2023 2024 0 0 0 0 0

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for GXAI. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
GXAI Price Earnings VS Forward Price EarningsGXAI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
GXAI Per share dataGXAI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 -1 2

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

GXAI does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

GAXOS.AI INC

NASDAQ:GXAI (9/12/2025, 8:00:01 PM)

After market: 1.7106 -0.01 (-0.55%)

1.72

-0.01 (-0.58%)

Chartmill FA Rating
GICS IndustryGroupMedia & Entertainment
GICS IndustryEntertainment
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners6.79%
Inst Owner Change88.91%
Ins Owners3.17%
Ins Owner ChangeN/A
Market Cap12.25M
AnalystsN/A
Price TargetN/A
Short Float %2.64%
Short Ratio0.03
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 61.63
P/FCF N/A
P/OCF N/A
P/B 0.82
P/tB 0.86
EV/EBITDA N/A
EPS(TTM)-1.15
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.57
FCFYN/A
OCF(TTM)-0.49
OCFYN/A
SpS0.03
BVpS2.11
TBVpS2
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -23.62%
ROE -24.23%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-92.62%
ROA(5y)N/A
ROE(3y)-114.35%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score6
Asset Turnover0.01
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 489.47%
Cap/Sales 285.25%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 28.68
Quick Ratio 28.68
Altman-Z 18.37
F-Score6
WACC8.7%
ROIC/WACCN/A
Cap/Depr(3y)801.83%
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)51.92%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)1233.33%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y6.54%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-85.46%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-64.08%
OCF growth 3YN/A
OCF growth 5YN/A